Clinical Predictors of Extracorporal Shockwave Therapy Efficacy in Patients Presenting With Lateral Hip Pain
试验速览
- 阶段
- 不适用
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Global Rating of Change Scale
研究概览
简要总结
This pragmatic clinical trial is considering the variable response to treatment outcome of individuals with Greater Trochanteric Pain Syndrome (GTPS). The aim of this study is to identify predictors of focused extracorporeal shockwave therapy (fESWT) efficacy in individuals with GTPS. Specifically, the ability of clinically applicable measurements including: Patient demographics, co-morbidity, oestrogen levels, pain characteristics, hip abductor strength, time to pain during single-leg stance test, low back pain, and immediate pain reduction to local anaesthetic injection at the trochanter major insertion of Gluteus medius (GMed) during walking.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Lateral hip pain, worst over the greater trochanter, present for a minimum of 3 months
- •Age 35-70 years
- •Pain at an average intensity of ≥3 out of 10 on most days of the last week.
- •Tenderness on palpation of the greater trochanter
- •Pain on one of the following:
- •Reproduction of pain on 30 sec single leg stand OR Positive Faber test
排除标准
- •Any known advanced hip joint pathology where groin pain is the primary complaint and/or reproduction of groin pain with Faber or FADDIR.
- •Where range of pure hip joint flexion is <90°
- •Radiating pain distal to the Gluteus Max + positive Straight Leg Raise (SLR-test < 30°)
- •Known advanced knee pathology or restricted range of knee motion (must have minimum 90° flexion and full extension)
- •Any systemic diseases affecting the muscular or nervous system, and uncontrolled diabetes
- •Malignant tumour OR Systemic inflammatory disease
- •Any factors that would preclude the participant from having an MRI (e.g. pacemaker, metal implants, pregnancy, claustrophobia)
- •If the participant is involved in a legal/workcover or other injury claim
- •Fear of needles (trypanophobia)
- •If the participant is unable to write, read or comprehend Danish
结局指标
主要结局
Global Rating of Change Scale
时间窗: 3 months follow-up
次要结局
- PHQ9(0, 12 and 26 weeks follow-up)
- VISA-G(0, 12 and 26 weeks follow-up)
- Patient-Specific Functional Scale).(0, 6, 12 and 26 weeks follow-up)
- Pain Pressure Threshold(0, 12 and 26 weeks follow-up)
- EuroQoL(0, 12 and 26 weeks follow-up)
- Muscle strength Static(0, 12 and 26 weeks follow-up)
研究者
Carsten Møller Poulsen Mølgaard
Clinical research physiotherapist
Aalborg University Hospital